|
ZNF606 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.995700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.522900E-03 |
| Normal-vs-Stage2 |
9.257800E-02 |
| Normal-vs-Stage3 |
3.390300E-04 |
| Normal-vs-Stage4 |
1.336990E-03 |
| Stage1-vs-Stage2 |
5.157600E-01 |
| Stage1-vs-Stage3 |
7.576000E-02 |
| Stage1-vs-Stage4 |
7.991600E-02 |
| Stage2-vs-Stage3 |
9.192200E-02 |
| Stage2-vs-Stage4 |
8.367800E-02 |
| Stage3-vs-Stage4 |
7.352000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.991820E-04 |
| Normal-vs-AfricanAmerican |
1.950030E-01 |
| Normal-vs-Asian |
4.291600E-02 |
| Caucasian-vs-AfricanAmerican |
3.459400E-01 |
| Caucasian-vs-Asian |
1.934970E-01 |
| AfricanAmerican-vs-Asian |
9.023800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.265800E-02 |
| Normal-vs-Female |
8.176200E-04 |
| Male-vs-Female |
1.848090E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.455400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.039590E-03 |
| Normal-vs-Age(61-80Yrs) |
4.238100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.174400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.037400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.238000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.382000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.701600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.869600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.928800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.501520E-03 |
| Classical-VS-Follicular |
4.783000E-01 |
| Classical-VS-Other |
4.608800E-01 |
| Classical-VS-Normal |
9.240900E-03 |
| Tall-VS-Follicular |
1.882880E-03 |
| Tall-VS-Other |
1.773580E-01 |
| Tall-VS-Normal |
2.21779999999283E-05 |
| Follicular-VS-Other |
6.729000E-01 |
| Follicular-VS-Normal |
5.137900E-02 |
| Other-VS-Normal |
6.482000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.135500E-03 |
| Normal-vs-N1 |
8.004600E-03 |
| N0-vs-N1 |
4.030000E-01 |
|
|
